Endobronchial Optical Coherence Tomography as a Novel Method for In Vivo Microscopic Assessment of Interstitial Lung Abnormalities

Am J Respir Crit Care Med. 2024 Jan 11. doi: 10.1164/rccm.202310-1871LE. Online ahead of print.

¹ Massachusetts General Hospital, Pathology, Boston, Massachusetts, United States; LHARIRI@mgh.harvard.edu.
² Massachusetts General Hospital, Radiology, Boston, Massachusetts, United States.
³ Massachusetts General Hospital, Division of Pulmonary and Critical Care Medicine, Boston, Massachusetts, United States.
⁴ Massachusetts General Hospital, 2348, Boston, Massachusetts, United States.
⁵ University of Washington, 7284, Division of Pulmonary and Critical Care Medicine, Seattle, Washington, United States.
⁶ Beth Israel Deaconess Medical Center, 1859, Internal Medicine, Boston, Massachusetts, United States.
⁷ Massachusetts General Hospital, Thoracic Surgery, Boston, Massachusetts, United States.
⁸ Massachusetts General Hospital, 2348, Division of Pulmonary and Critical Care Medicine, Boston, Massachusetts, United States.
⁹ Massachusetts General Hospital, Interventional Pulmonology, Boston, Massachusetts, United States.

No abstract available

Keywords: in vivo microscopy; optical imaging; presymptomatic pulmonary fibrosis; prognostic biomarker; subclinical interstitial lung disease.